Trials / Completed
CompletedNCT02089269
Tumor Registry Pancreatic Cancer
Clinical Registry on Treatment Reality and Sequential Treatments of Patients with Resectable or Locally Advanced/metastatic Pancreatic Cancer in Real-life Practice in Germany
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,325 (actual)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The registry aims to collect and analyse information on the antineoplastic treatment of patients with unresectable locally advanced or metastatic pancreatic cancer, treated in palliative intention (cohort 1) and patients with localized, resectable pancreatic cancer treated in neo-adjuvant or adjuvant intention (cohort 2) in daily routine practice in Germany. The registry will follow up patients for two years. It will identify common sequences of treatments used as well as changes in the treatment of the disease. Health-related quality of life will be analysed during the course of the treatment (PanLife). Based on the available data a prognostic score will be developed.
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2022-04-14
- Completion
- 2024-06-01
- First posted
- 2014-03-17
- Last updated
- 2025-01-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02089269. Inclusion in this directory is not an endorsement.